Design of a composite biomaterial system for tissue engineering applications

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Vascularized tissue formation is crucial for tissue replacement and reconstruction.
• Current methods require biomaterials that can regulate and support new vessel growth.
• Developing scaffolds with controlled growth factor delivery is essential for effective tissue regeneration.

Purpose of the Study:

• To engineer a porous, degradable tissue engineering scaffold capable of delivering multiple growth factors.
• To regulate vessel assembly within the scaffold's porous structure.
• To investigate the impact of sequential growth factor delivery on neovascularization and tissue ingrowth.

Main Methods:

• Preparation of porous poly(ethylene glycol)-co-(L-lactic acid) (PEG-PLLA) hydrogels via salt leaching.
• Incorporation of fibrin for rapid growth factor release and poly(lactic-co-glycolic acid) (PLGA) microspheres for sustained release.
• Delivery of fibroblast growth factor-1 (FGF-1) and platelet-derived growth factor-BB (PDGF-BB) to promote angiogenesis and vascular stabilization.
• In vivo testing using a subcutaneous implantation model.

Main Results:

• Degradation time of hydrogels was controllable (1-7 weeks).
• Dual growth factor delivery significantly increased tissue ingrowth compared to single or no growth factor delivery.
• Sequential delivery of FGF-1 after PDGF-BB resulted in more persistent and mature blood vessels.
• In vitro release kinetics and degradation profiles guided in vivo study selection.

Conclusions:

• A novel biomaterial system was developed for tissue regeneration.
• The scaffold provides structural support and controlled delivery of growth factors.
• The system effectively stimulates neovascularization within the scaffold structure.
• Sequential growth factor delivery enhances the quality and maturity of newly formed blood vessels.